重症患者中流感相关与COVID-19相关肺曲霉病
本综述讨论重症流感相关肺曲霉病(IAPA)和COVID-19相关肺曲霉病(CAPA)的机制与临床方面。在重症流感或COVID-19患者中,使用适当诊断工具时通常10-20%可诊断。尽管抗真菌治疗,病死率常超过50%。
要点
- 重症流感或COVID-19患者中IAPA/CAPA诊断率约10-20%,需适当诊断工具。
- 支气管肺泡灌洗培养、半乳糖甘露聚糖检测和PCR是诊断基石。
- 唑类为首选抗真菌药,脂质体两性霉素B为替代。
核心结论
- IAPA和CAPA是重症病毒性肺炎患者的重要并发症,尽管抗真菌治疗病死率常超过50%。
研究设计与样本
- 综述,讨论IAPA和CAPA的机制与临床方面,并指出知识空白与未来研究方向。
主要发现
- 在重症流感或COVID-19患者中,使用适当诊断工具时通常10-20%可诊断IAPA或CAPA。
- 支气管肺泡灌洗培养、半乳糖甘露聚糖检测和PCR是诊断基石。
- 支气管镜下气管支气管树可视检查用于检测侵袭性曲霉性气管支气管炎。
- 唑类为首选抗真菌药,脂质体两性霉素B在唑类耐药普遍地区作为替代。
- 尽管抗真菌治疗,IAPA和CAPA病死率常超过50%。
关键数值与推荐
- 诊断率:重症流感或COVID-19患者中10-20%可诊断IAPA或CAPA(使用适当诊断工具时)。
- 治疗:唑类为一线,脂质体两性霉素B为唑类耐药普遍地区的替代。
- 预后:IAPA和CAPA病死率常超过50%。
临床怎么用
- 对重症流感或COVID-19患者应使用支气管肺泡灌洗培养、半乳糖甘露聚糖检测和PCR诊断IAPA/CAPA。
- 支气管镜检查可视评估气管支气管树以检测侵袭性曲霉性气管支气管炎。
- 首选唑类治疗,唑类耐药普遍地区可选用脂质体两性霉素B。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated pulmonary aspergillosis (CAPA) are increasingly recognised as important complications in patients requiring intensive care for severe viral pneumonia. The diagnosis can typically be made in 10-20% of patients with severe influenza or COVID-19, but only when appropriate diagnostic tools are used. Bronchoalveolar lavage sampling for culture, galactomannan testing, and PCR forms the cornerstone of diagnosis, whereas visual examination of the tracheobronchial tract during bronchoscopy is required to detect invasive Aspergillus tracheobronchitis. Azoles are the first-choice antifungal drugs, with liposomal amphotericin B as an alternative in settings where azole resistance is prevalent. Despite antifungal therapy, IAPA and CAPA are associated with poor outcomes, with fatality rates often exceeding 50%. In this Review, we discuss the mechanistic and clinical aspects of IAPA and CAPA. Moreover, we identify crucial knowledge gaps and formulate directions for future research.
引用
- Feys S, Carvalho A, Clancy CJ, et al. Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients. Lancet Respir Med. 2024. PMID: 39025089. doi:10.1016/S2213-2600(24)00151-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。